Participated · Seed · Sep 2024

Bambusa Therapeutics is pioneering a half-life-extended, high-concentration subcutaneous bispecific antibody platform aimed at transforming treatment across a broad range of chronic immunology and inflammation (I&I) diseases. Its lead assets, BBT001 (targeting IL-4Rα and IL-31) and BBT002 (targeting IL-4Rα and IL-5), have already advanced into Phase I trials for dermatology, respiratory and other Type 2 inflammatory disorders. In just 18 months the company moved these programs from development candidate to clinical proof-of-concept, demonstrating unusually rapid execution for I&I biologics. Preclinical candidates BBT003 and BBT004 will address gastroenterology and rheumatology indications, respectively, with IND-enabling studies funded by the latest raise. Bambusa anticipates more than ten clinical readouts across multiple indications in 2026, positioning the company for significant value inflection. Although the company has not disclosed revenues or user numbers, the oversubscribed Series A-2 round closed at a “substantial valuation step-up,” signaling strong investor confidence and an improved financial position.

Led · Seed · Nov 2023

InPlanet develops enhanced rock weathering (ERW) solutions for tropical agriculture, spreading locally sourced rock powders on farmland to accelerate natural CO2 mineralization and improve soil fertility. The company pairs deployments with rigorous measurement, reporting and verification (MRV) and a scientific program that samples solid, liquid and gaseous phases and uses carbon mass balance, trace element and DIC measurements to quantify removal. InPlanet aims to both remove atmospheric CO2 and reduce farmers' reliance on synthetic fertilizers by boosting nutrient availability and crop yields. The team plans to scale MRV capabilities and operational deployments, targeting large‑scale rock spreading in the tropics. Operational targets in the announcement include spreading 200,000 metric tons of rock powder to capture 40,000 metric tons of CO2 and keeping on pace to remove 1 million metric tons of CO2 by 2026. The company has publicly disclosed prior pre‑seed funding and is positioning itself as a science‑driven CDR and agro‑tech provider in tropical markets. InPlanet deploys enhanced rock weathering by supplying and spreading finely ground rock powder on tropical agricultural land to accelerate natural CO2-consuming chemical reactions. The company positions the rock powder as a decarbonised soil amendment that can help restore tropical soils and substitute for limestone, pesticides and synthetic fertilisers. InPlanet plans to build a scalable enhanced rock weathering station in the tropics and, with the current program, will spread 50,000 tonnes of rock powder to remove an estimated 10,000 tonnes of CO2. The startup aims to scale toward preventing carbon megatonnes from entering the atmosphere by 2030. InPlanet is Germany/Brazil-HQed and works with scientific partners at the University of São Paulo and Universidade de Brasília. It participates in the Frontier Batch and ClimAccelerator programmes and plans to use new funding to grow its team.

Led · Series A · Mar 2023

OQmented develops ultra-compact MEMS-based light engines using laser beam scanning to enable wearable augmented and mixed reality glasses for tech companies and eyeglass manufacturers. Its laser beam scanning approach aims to deliver lower power consumption, smaller size, higher brightness and contrast, and improved display performance. The company has a team of around 80 people and operates five offices globally. OQmented was founded in 2018 by Thomas von Wantoch and Dr. Ulrich Hofmann and is based in Itzehoe, Germany. The startup plans to use the new funding to hire several key employees and strengthen its business development team to access the US and Asian markets. The article reports a $20M Series A financing as the company's current funding event. OQmented develops and sells high-performance MEMS mirrors for ultra-compact LBS displays and best-in-class 3D sensing solutions. Its one-chip projection display leverages a Lissajous scan pattern, patented Bubble MEMS® vacuum packaging, and proprietary electronics and software. The company aims to commercialize its MEMS mirror-based LBS technology for AR/VR smart glasses to enable powerful visualization in a lightweight frame. OQmented plans to use new funding to expand its Itzehoe location, accelerate R&D, and foster and establish partnerships to fast-track market penetration. The product is positioned to enable applications such as 3D cameras, LiDAR, and machine vision and to help bring AR/VR technologies into the mainstream. Financially, the company extended its seed round with an additional USD 9.3M and has raised nearly USD 20M since its 2018 spin-out from the Fraunhofer Institute.

Participated · Series A · Jul 2022

IQM Quantum Computers is a Finland-based developer of quantum computing technology. The company is preparing for public listings on Nasdaq and the Helsinki Stock Exchange. Ahead of those listings, IQM secured $146 million in PIPE financing tied to a SPAC combination with Real Asset Acquisition Corp., including a new commitment from Ilmarinen. IQM plans to use the funds to advance its technology and scale commercial operations. The financing strengthens the company’s near-term financial position as it moves toward becoming a public company.

Participated · Series B · Dec 2021

Mimi offers an at‑home hearing testing app and an SDK that lets headphone and TV makers deliver customized audio tuned to a user’s hearing profile. The company reports about 50,000 people per month using its at‑home hearing test. Mimi has secured partnerships with consumer audio brands including Skullcandy, Cleer and Beyerdynamic, and has developed TV tests for Philips. Its platform aims to improve listening without raising volume, with the intention of preventing further hearing damage. Management says the new capital will be used to further develop the technology, expand headphone and TV integrations, and ramp up sales and marketing across the U.S. and Asia. Company executives quoted include CEO and founder Philipp Skribanowitz, R&D head and founder Nick Clark, and CFO Moritz Bratzke.